HMD Pharmaceutical Consulting LLC offers a unique approach to consulting that will enhance your project with timely, market-focused advice. With a background combining industry experience, an active medical practice and an active presence in academia, Dr. Howard Druce responds quickly with input based on your needs and regulatory agency requirements.
Rx-to-OTC switch advice and support with special expertise in cough-cold, allergy, pulmonary, smoking cessation, eye care
Access to key medical opinion leaders
Developing strategic portfolio programs
Presentations to regulatory agencies
Due diligence for potential in-licensing acquisitions
Data analysis and insight for development of robust advertising claims
State-of-the-art literature reviews with interpretation
Participation in advisory boards and panels
Member, FDA Pulmonary-Allergy Drugs Advisory Committee, industry representative
Design of clinical trial programs, Phase II-IV and Rx-to-OTC switch study protocols and clinical development plans
Writing clinical study reports, scientific abstracts and publications
Medical monitoring of clinical trials in many therapeutic areas